Allama Iqbal Medical College
15 imported, source-linked research records. All imported publication dates.
15 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Allama Iqbal Medical College are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–15 of 15 matching records. Counts update as records arrive.
Meta-Analysis Evaluating the Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure Stratified by Frailty Index
April 1, 2026 · 0 citations
Open original record →Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis
February 26, 2026 · 6 citations · Open access
Open original record →Correction: Effect of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in patients with type 2 diabetes in the United States: a TriNetX database study
February 16, 2026 · 0 citations · Open access
Open original record →Cardioprotective effects of Sodium-Glucose cotransporter-2 inhibitors in patients undergoing ventricular tachycardia (VT) ablation: a propensity-matched cohort study
December 6, 2025 · 2 citations
Open original record →“Efficacy of SGLT2 inhibitors in non-diabetic non-alcoholic fatty liver disease: a systematic review and meta-analysis”
December 4, 2025 · 7 citations · Open access
Open original record →Abstract 4357987: Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Patients undergoing Ventricular Tachycardia (VT) Ablation: A Propensity-Matched Cohort Study
November 3, 2025 · 0 citations
Open original record →Effect of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in patients with type 2 diabetes in the United States: a TriNetX database study
October 24, 2025 · 3 citations
Open original record →Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Patients undergoing Ventricular Tachycardia (VT) Ablation: A Propensity-Matched Cohort Study
October 5, 2025 · 0 citations · Open access
Open original record →Comparing the Efficacy and Long-Term Outcomes of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Metformin, and Insulin in the Management of Type 2 Diabetes Mellitus
November 25, 2024 · 5 citations · Open access
Open original record →Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis
September 30, 2024 · 10 citations · Open access
Open original record →The Comparison of the Effectiveness of Dapagliflozin and Empagliflozin in the Prevention of Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Network Meta-Analysis
September 19, 2024 · 4 citations · Open access
Open original record →Efficacy of Sodium‐Glucose Cotransporter‐2 Inhibitors in Patients With Acute Myocardial Infarction: A Meta‐Analysis of Randomised Controlled Trials
August 15, 2024 · 25 citations · Open access
Open original record →Investigating the Role of Sodium-glucose Cotransporter-2 Inhibitors in Slowing Down the Diabetic Kidney Disease Progression: A Meta-analysis of Randomized Control Trials
May 13, 2024 · 0 citations · Open access
Open original record →Integrating Medicine and Pharmacology: The Burden of Heart Failure in Diabetes, Its Treatment Patterns and Consequences for Patient Quality of Life
December 28, 2023 · 0 citations · Open access
Open original record →Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
September 30, 2023 · 60 citations · Open access
Open original record →